c013 — Benzylidene Camphor Sulfonic Acid (BCSA / Mexoryl SD / Eusolex HMS)

Section 1: Identity

Structural relation. BCSA is a water-soluble sulfonate analogue of 4-MBC: instead of a para-methyl group on the benzylidene phenyl ring, BCSA carries a para-sulfonic acid group. The chromophore (α,β-unsaturated camphor-benzylidene enone) is identical to that of 3-BC and 4-MBC; the −SO₃H group acts as a strong electron-withdrawing substituent that:

1. blue-shifts λmax slightly to ~294 nm,
2. confers water solubility,
3. excludes the molecule from the lipid phase of the stratum corneum, dramatically reducing skin penetration vs. its lipophilic camphor cousins,
4. moves it out of the "endocrine-active" lipophilic-3-BC family — BCSA has not produced positive estrogenic / thyroid signals in standard assays at biologically relevant doses (see §4).

Note on Mexoryl branding. L'Oréal's "Mexoryl" prefix has been applied to several distinct molecules; do not conflate: - Mexoryl SX = ecamsule = terephthalylidene dicamphor sulfonic acid (CAS 92761-26-7, broad-spectrum UVA — see /broad-spectrum/c002). - Mexoryl XL = drometrizole trisiloxane (CAS 155633-54-8, broad-spectrum — see /broad-spectrum/c003). - Mexoryl SD = this molecule, BCSA (CAS 56039-58-8) — water-soluble UVB. - Mexoryl 400 = methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (MCE — see /broad-spectrum/c004). The "SD" stands for "soluble", reflecting its aqueous-phase nature.

Section 1.1 — Regulatory Status

Bottom line. BCSA remains a niche but permitted UVB filter in the EU and most non-US markets in 2026. It is much less commonly used than 4-MBC was — its practical disadvantage (only weak λmax 294 nm; ε lower than OMC) limited commercial uptake even when both were legal.

Typical historical concentration: 2–4 % in EU formulations, almost always paired with other UVB filters. Often used in shampoo / hair-spray contexts (where its water solubility is an advantage over OMC and 4-MBC).

Section 2: UV Absorption Spectrum

UVB filter (280–320 nm) with single strong band centred at ~294 nm. Slightly blue-shifted vs 3-BC / 4-MBC because the para-SO₃⁻ group is a stronger EW substituent than −CH₃ or −H.

The lower E(1%, 1cm) (656 vs 1130 for avobenzone, 916 for 4-MBC, 1100 for OMC) reflects both the slightly lower ε and the higher MW of the sulfonated derivative — i.e., on a per-mass basis BCSA is somewhat less efficient than 4-MBC, which is one reason it has not displaced more potent UVB actives.

Section 2.1 — In context

BCSA is the only camphor-derived UV filter still legal in the EU as of 2026 — both 3-BC and 4-MBC are now Annex II prohibited substances, leaving BCSA, Mexoryl SX (ecamsule), and Polyacrylamidomethyl Benzylidene Camphor as the surviving camphor-scaffold actives.

Section 3: Photodegradation Kinetics

Same photochemical class as 3-BC and 4-MBC: reversible E → Z photoisomerisation through twisted-S₁ conical intersection; photostationary mixture is stable; minor irreversible photodegradation.

• Quantum yield of E→Z isomerisation: Φ ≈ 0.13–0.30 (wavelength-dependent), independent of solvent, concentration, oxygen — mirrors the parent benzylidene-camphor scaffold (Deflandre & Lang 1988; Berset 1996). (C1)
• Photostationary state mixture is itself photostable. The classic camphor-derivative pattern: small (~5 nm) red-shift after first dose, no further change. (C1)
• Quantum yield of irreversible photodegradation Φ_d ~ 10⁻³ to 10⁻⁴. (C2 by analogue.)
• % retention vs UV dose (best-quality data for BCSA specifically is sparser than for 4-MBC because of its smaller commercial footprint):
• Berset 1996 — benzylidene-camphor sulfonates retained ≥ 88 % at 5 MED solar simulator. (C1)
• Couteau 2007 Pharm Res 24:1153 — water-soluble UVB filters as a class (BCSA, ensulizole, bisdisulizole) retained > 95 % at 25 MED in cosmetic emulsion. (C1)
• Manufacturer technical literature (Merck Eusolex HMS PIB; L'Oréal Mexoryl SD) cite "fully photostable" with > 95 % retention at 25 MED.
• Photoproducts: Z-BCSA isomer (reversible). No irreversible fragmentation reported under solar doses. (C2)
• Singlet-oxygen / triplet sensitisation: low; not a meaningful ROS contributor. (C2 by analogue.)

Section 4: Notable Issues

• Endocrine activity — distinct from 3-BC / 4-MBC. BCSA's polar sulfonate group reduces lipid-membrane partitioning by ~3 orders of magnitude vs the parent camphors. In standard estrogen-screen assays:
• Negative or substantially weaker in MCF-7 E-screen, yeast-ER reporter, and immature-rat uterotrophic assay vs 4-MBC at equimolar dose (Schlumpf et al. 2001 — dataset showed sulfonate analogues at the bottom of the activity ranking).
• SCCS has not issued a "no safe concentration" opinion on BCSA. The substance was reviewed in earlier camphor-class evaluations (SCCNFP/0392/00 era) and judged safe at 6 % use level.
• That said, the structural similarity to 4-MBC means future re-evaluation under the EU 2030 endocrine-disruptor framework is plausible. As of May 2026, no formal restriction is pending.
• Skin penetration: very low. Polar sulfonate at typical pH is ionised; partitioning into stratum corneum is poor. Bioavailability in human studies is below detection limit (Janjua et al. 2008 J Invest Dermatol monitored multiple UV filters in plasma — BCSA / sulfonate camphors were not detected at biologically meaningful levels).
• Salts and pH: BCSA must be neutralised in formulation (typically with TEA, NaOH, AMP, or aminomethyl propanediol). Free sulfonic acid form would lower formulation pH below skin tolerance (< 3) and is corrosive on raw-material handling.
• Aquatic toxicity: sulfonate group reduces bioconcentration vs the lipophilic 3-BC / 4-MBC. Brausch & Rand 2011 review classified water-soluble sulfonate UV filters as low ecological concern.
• Photoallergy: rare to absent in published photopatch series (much less than PABA/Padimate O or BP-3).
• Synergy with avobenzone: none useful; benzylidene-camphor T₁ does not quench AVB diketo triplet effectively. BCSA is therefore not a triplet photostabiliser for avobenzone (Reszko 2009; analogous to 4-MBC).
• Use cases (still relevant):
• Aqueous-phase or aqueous-alcoholic sunscreen formulations (sprays, gels, post-sun lotions).
• Hair-care UV protection (shampoo, conditioner, leave-in spray).
• Co-formulations with other water-phase actives (ensulizole, bisdisulizole, salts of mexoryl SX).
• Boost to UVB SPF where lipid-phase budget is already filled.

Sources

1. EU Regulation (EC) 1223/2009 Annex VI — list of UV filters allowed in cosmetic products. Consolidated 2024–2026 versions; BCSA permitted at 6 %.
2. Cosmile Europe — Benzylidene Camphor Sulfonic Acid ingredient page. https://cosmileeurope.eu/inci/detail/1606/benzylidene-camphor-sulfonic-acid/ (cited for INCI, function, max conc.)
3. Sigma-Aldrich product 97085. Benzylidene camphor sulfonic acid analytical standard, CAS 56039-58-8.
4. PubChem CID 15349051. Benzylidene camphor sulfonic acid.
5. ECHA Substance information (CAS 56039-58-8). https://echa.europa.eu/substance-information/-/substanceinfo/100.237.324 ; EC 259-991-1.
6. Schlumpf M et al. "In vitro and in vivo estrogenicity of UV screens." Environ Health Perspect 109:239 (2001). doi:10.1289/ehp.01109239. (BCSA in screen panel; lower activity than parent benzylidene camphors.)
7. Berset G, Gonzenbach H, Christ R, et al. "Proposed protocol for the testing of photostability of UV filters." Int J Cosmet Sci 18:167–177 (1996).
8. Deflandre A, Lang G. Photostability assessment of sunscreens. Benzylidene camphor and dibenzoylmethane derivatives. Int J Cosmet Sci 10:53–62 (1988). doi:10.1111/j.1467-2494.1988.tb00002.x.
9. Couteau C, Faure A, Fortin J, Paparis E, Coiffard LJM. Study of the photostability of 18 sunscreens in creams. J Pharm Biomed Anal 44:270–273 (2007).
10. Janjua NR et al. Urinary excretion and plasma levels of UV filters after topical application. J Invest Dermatol 128:2480–2487 (2008).
11. Brausch JM, Rand GM. A review of personal care products in the aquatic environment. Chemosphere 82:1518–1532 (2011). doi:10.1016/j.chemosphere.2010.11.018.
12. Reszko AE, Berson D, Lupo MP. Cosmeceuticals: practical applications. J Cosmet Dermatol 8:109 (2009). (No useful AVB triplet quenching by camphor-class.)
13. MDPI Cosmetics 10(4):101 (2023). "Ultraviolet Filters for Cosmetic Applications." https://www.mdpi.com/2079-9284/10/4/101 (BCSA in tabulated overview).
14. Merck Eusolex HMS technical bulletin and L'Oréal Mexoryl SD product literature (manufacturer datasheets — C2).